A detailed history of High Point Advisor Group LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 788 shares of MEDP stock, worth $342,267. This represents 0.01% of its overall portfolio holdings.

Number of Shares
788
Previous 790 0.25%
Holding current value
$342,267
Previous $240,000 2.92%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

SELL
$277.23 - $315.28 $554 - $630
-2 Reduced 0.25%
788 $247,000
Q1 2025

May 05, 2025

SELL
$304.69 - $360.97 $1,523 - $1,804
-5 Reduced 0.63%
790 $240,000
Q4 2024

Feb 12, 2025

BUY
$308.93 - $363.58 $48,810 - $57,445
158 Added 24.8%
795 $264,000
Q3 2024

Nov 04, 2024

BUY
$320.58 - $457.29 $204,209 - $291,293
637 New
637 $212,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $13.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.